| Literature DB >> 24631520 |
Leonard Angka1, Eric A Lee1, Sarah G Rota1, Thomas Hanlon1, Mahadeo Sukhai2, Mark Minden3, Elliott M McMillan4, Joe Quadrilatero4, Paul A Spagnuolo5.
Abstract
To identify novel anti-cancer agents, we created and screened a unique nutraceutical library for activity against acute myeloid leukemia (AML) cells. From this screen, we determined that glucopsychosine was selectively toxic toward AML cell lines and primary AML patient samples with no effect toward normal hematopoietic cells. It delayed tumor growth and reduced tumor weights in mouse xenograft models without imparting toxicity. Glucopsychosine increased cytosolic calcium and induced apoptosis through calpain enzymes. Extracellular calcium was functionally important for glucopsychosine-induced AML cell death and surface calcium channel expression is altered in AML cells highlighting a unique mechanism of glucopsychosine's selectivity. CrownEntities:
Keywords: Acute myeloid leukemia; Calcium; Calpain; Glucopsychosine; Nutraceuticals
Mesh:
Substances:
Year: 2014 PMID: 24631520 DOI: 10.1016/j.canlet.2014.03.003
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679